News
IconOVir Bio Announces Preclinical Proof-of-Concept Data for Proprietary Mutations Designed to Improve Selectivity of Novel Oncolytic Viruses, Including Lead Product Candidate ICVB-1042 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback